Basic Study
Copyright ©The Author(s) 2023.
World J Gastrointest Oncol. Feb 15, 2023; 15(2): 318-331
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.318
Figure 1
Figure 1 Evaluation of the tissue expression and diagnostic utility of microRNA-627 in the GSE41655 and GSE18392 datasets. A: Tissue expression of microRNA-627 (miR-627) in the healthy controls (HCs) and colorectal cancer (CRC) patients in the GSE41655 dataset; B: Tissue expression of miR-627 in the HCs and CRC patients in the GSE18392 dataset; C: Receiver operating characteristic analysis of miR-627 to distinguish CRC patients from HCs in the GSE41655 dataset; D: Receiver operating characteristic analysis of miR-627 to distinguish CRC patients from HCs in the GSE18392 dataset. HCs: Healthy controls; CRC: Colorectal cancer. bP < 0.01; cP < 0.001.